Navigation Links
New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management

Olympic Games Champion Nikki Stone and Chronic Pain Experts, Inspire Through Webcast Series

MONTCLAIR, N.J., Sept. 22 /PRNewswire/ -- The American Society of Pain Educators (ASPE) recently launched, the second of a three-part Webcast series: Is Your Persistent Chronic Pain Weighing You Down? at This Webcast addresses the importance of proper weight control in managing chronic pain.


-- Inspirational testimony from Olympic Gold Medalist and chronic pain sufferer Nikki Stone.

-- Practical pain management tips from Dr. Warren A. Katz, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine and Associate of the Rothman Institute.


While maintaining a healthy weight is important for a number of health-related reasons, it is particularly important for the more than 50 million Americans who suffer with persistent chronic pain. The significance for chronic pain sufferers to maintain a healthy diet and weight was underscored in the recent PRICARA(R) Chronic Pain Barometer online survey of 500 American chronic pain sufferers 18 years or older:

-- 86 percent of respondents stated that healthy changes to their diet helped to manage their chronic pain.

-- Nearly half of chronic pain sufferers (approximately 46 percent) agreed controlling their weight helped them to manage their chronic pain.

The Webcast series was developed to addresses everyday concerns for those who suffer with persistent chronic pain on the topics of exercise, weight control, and relationships, including intimacy. The first Webcast on exercise is currently archived at

Note: Funding for ASPE and Webcast series was provided by PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. All experts featured in the Webcasts and Nikki Stone are paid consultants for PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

About Nikki Stone, Olympic Gold Medalist

Best known for being the first American to win a gold medal in inverted aerial skiing, Nikki Stone understands what it is like to be living with persistent chronic pain, after experiencing a back injury from a skiing accident. Months after the injury, Nikki's pain continued on a daily basis and made it difficult for her to perform once simple activities. Her doctor diagnosed her as having persistent chronic pain and worked with her to develop a pain management plan. The plan that worked for Nikki included a prescription medication, which helped manage her pain so that she could participate in physical therapy to strengthen the muscles in her back. With the combination of medication, physical therapy, doctor supervision and tireless motivation, Nikki was able to work her way back to competing and became the first American to win a gold medal in inverted aerial skiing. Today, Nikki hopes to motivate others suffering with chronic pain to speak with their doctors to find a program to manage their pain.

About the Webcast Series

Over the coming months, each Webcast will be featured on, commencing in July. This Webcast is meant for educational purposes only, and every effort has been made to ensure that the information presented is accurate. Information presented in the Webcasts is not intended to replace the care prescribed by a healthcare professional.

The opinions expressed in the Webcasts are those of the speakers, presenters and Ortho-McNeil-Janssen Pharmaceuticals, Inc., and may not necessarily reflect the positions of the ASPE, or the Webhost. The appearance of the ASPE name and logo in the Webcasts does not constitute an endorsement of any products, services or information mentioned. The ASPE does not imply discrimination against other similar products or services.

Funding for ASPE and Webcast series was provided by PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

All experts featured in the Webcasts and Nikki Stone are paid consultants for PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

The PRICARA(R) Chronic Pain Barometer survey was conducted online from March 28-31, 2008, in partnership with HCD Research, Inc. on behalf of PRICARA(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., the marketer of ULTRAM(R) ER (tramadol HCl) extended release tablets, and involved 500 American adults, ages 18 and older, who self-identified as suffering from chronic pain.

About the American Society of Pain Educators (ASPE)

The ASPE is a 501(c)(3) non-profit professional organization dedicated to improving the standards of clinical pain practice. The goal of the ASPE is to promote optimal quality of life and physical functioning for pain sufferers by providing high-quality pain education training and continuing education programming for healthcare professionals.

The ASPE also provides educational opportunities for clinicians who wish to become Certified Pain Educators (CPEs). CPEs serve as specialized resources for pain management in their clinical settings, educating their professional colleagues--as well as patients, families and caregivers--on ways to relieve pain by the safest means possible. As the Joint Commission on Accreditation of Healthcare Organizations requires pain management education in all of its accredited institutions, the ASPE's goal is to eventually have a CPE in every JCAHO-accredited facility.

About ULTRAM(R) ER (tramadol HCl) Extended Release Tablets

ULTRAM(R) ER is used to manage moderate to moderately severe chronic pain in adults who need to be treated around the clock for their pain for an extended period of time. For more information, please visit


Do not take ULTRAM(R) ER if you have had an allergic reaction to tramadol, codeine, or other opioids in the past.

ULTRAM(R) ER tablets must be swallowed whole. Do not chew, crush or split the tablet before swallowing. This can lead to overdose and possible serious injury including death. Use of alcohol should be avoided when taking ULTRAM(R) ER.

The maximum daily dose of ULTRAM(R) ER is 300 mg. Do not change your dose or stop taking

ULTRAM(R) ER without talking with your doctor first.

Talk with your doctor about all the medications you are taking. These may include antidepressants, tranquilizers, hypnotics or other opioid pain medicines. ULTRAM(R) ER may impair your ability to perform potentially hazardous tasks, such as driving a car or operating machinery.

Seizures have been reported in people taking tramadol, the medicine in ULTRAM(R) ER. The risk of seizures is increased with doses of tramadol above the recommended range. Use of tramadol increases the risk of seizures in people taking antidepressants, other opioids, or other drugs that can cause seizures. Risk of convulsions may also increase in people with epilepsy or a history of seizures.

ULTRAM(R) ER may be associated with a potentially life-threatening condition when taken together with selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs) (classes of drugs for depression or other disorders), triptans, lithium, or St. John's Wort. Some common SSRIs are Paxil(R) (paroxetine), Prozac(R)/Sarafem(R) (fluoxetine), and Zoloft(R) (sertraline). Some common SNRIs are Cymbalta(R) (duloxetine) and Effexor(R) (venlafaxine). Some common triptans are Axert(R) (almotriptan), Imitrex(R) (sumatriptan), and Relpax(R) (eletriptan).

If you experience symptoms such as restlessness, hallucinations, loss of coordination, fast heartbeat, rapid changes in blood pressure, increased body temperature, overactive reflexes, nausea, vomiting, and diarrhea, contact your doctor immediately.

ULTRAM(R) ER, like other opioids, can be abused or cause dependence. People who are suicidal or have a history of drug addiction should not take ULTRAM(R) ER. Do not take more than the recommended dose of ULTRAM(R) ER. Taking more than the recommended dose of ULTRAM(R) ER, alone or in combination with alcohol or medications such as tranquilizers, hypnotics or other opioids, can cause respiratory depression, seizures, overdose and possibly death.

Tell your doctor about all your medical conditions and if you are pregnant, think you might be pregnant or are trying to become pregnant.

The most common side effects reported with ULTRAM(R) ER were dizziness, nausea, constipation, headache, and drowsiness.

Please see full Prescribing Information available at

Paxil and Imitrex are registered trademarks of GlaxoSmithKline. Prozac and Cymbalta are registered trademarks of Eli Lilly. Sarafem is a registered trademark of Warner Chilcott. Zoloft and Relpax are registered trademarks of Pfizer, Inc. Effexor is a registered trademark of Wyeth. Axert is a registered trademark of Almirall Prodesfarma.


Redza Ibrahim Sarah Bailey

American Society of Pain Educators Ruder Finn Public Relations

Tel (973) 679-4485 Tel (212) 715-1619

Fax (973) 556-1058 Fax (646) 792-4424

SOURCE The American Society of Pain Educator
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Webcast Alert: Kaiser Permanente Residency Program Open House
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
4. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
5. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
6. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
7. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
10. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
11. Par Invites Public to Listen to Webcast of its September 28 Analysts Meeting
Post Your Comments:
(Date:11/27/2015)... ... ... The rapid speed at which Americans are aging is ... needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. Health ... of this equation: 80 percent of medical care occurs in the home, by ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... $15.8  Million to expand its laboratories and global ... The expansion will provide additional office space and ... of the pharmaceutical and biotechnology markets. ... up to 40,000 square feet of expanded development ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology: